⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CASI News
CASI Pharmaceuticals, Inc. Ordinary Shares
G-SHOCK Introduces the GRAVITYMASTER GWRB3000 Series Inspired by Supersonic Flight
prnewswire.com
CASI
Necrotizing Enterocolitis Market to Register Stunning Growth at a CAGR of 26% During the Forecast Period (2026–2036) | DelveInsight
globenewswire.com
JAGX
MRK
CASI
JAZZ
Delisting of Securities from The Nasdaq Stock Market
globenewswire.com
MLGO
EPWK
IVP
SYNX
TWIN
FAT
CASI
TRX
ITRM
IOBT
CASI Pharmaceuticals Receives the Delisting Decision From the Nasdaq Hearings Panel
accessnewswire.com
CASI
CASI Pharmaceuticals Announces Approval of Clinical Trial Application by China NMPA for Phase 1 / 2 Study of CID-103 for Renal Allograft Antibody-Mediated Rejection (AMR)
accessnewswire.com
CASI
CASI Pharmaceuticals Announces Update and Additional Results from Phase 1 Study of CID-103 in Adult Patients with Chronic Immune Thrombocytopenia
accessnewswire.com
CASI
CASI Pharmaceuticals Receives Extension from Nasdaq to Meet Listing Requirements
accessnewswire.com
CASI
CASI Pharmaceuticals Announces Up to $20 Million Convertible Note Financing
accessnewswire.com
CASI
CASI Pharmaceuticals Announces Results from CID-103 Immune Thrombocytopenia Study at the 67th American Society of Hematology (ASH) Annual Meeting
accessnewswire.com
CASI
CASI Pharmaceuticals Announces Changes in Board Governance
accessnewswire.com
CASI